Eurofins-Cerep SA (ALECR.PA)

20600 €

0.00 (0.00%)
Rating:
Recommendation:
-
Symbol ALECR.PA
Price 20600 €
Beta 0.605
Volume Avg. -
Market Cap 103.906M
Shares () -
52 Week Range 13100.0-22400.0
1y Target Est -
DCF Unlevered ALECR.PA DCF ->
DCF Levered ALECR.PA LDCF ->
ROE 11.14% Buy
ROA 7.10% Neutral
Operating Margin -
Debt / Equity 31.63% Neutral
P/E 10.56 Strong Buy
P/B 2.29 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Mr. Antoine Duthilleul
Healthcare
Diagnostics & Research
Paris

Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.